Kane Biotech Inc. V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.

TSXV:KNE - Post by User

Kane Biotech Inc.

Bullboard Posts

Post by pmrideron Apr 19, 2011 3:47pm

357 Views

Post# 18455757

Chrave

One of the investors that took down a good piece of the latest PP was Steve Palmer from Alpha North. Alpha North has had a very hot hand of late. Have a look at V.INT today. It has traded 130+ million shares today. If this is the type of shareholder that you are concerned about, please bring on the concerns - the more the merrier.

V.INT was .11 at the end of January 2011. Today it touched 3.35. Can't help but think that Steve Palmer et. al. will bring a good contingent of that following into the KNE story.

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects